Adjusted Financial Ratios (Summary)
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).
Financial ratio | Description | The company |
---|---|---|
Adjusted total asset turnover | An activity ratio calculated as total revenue divided by adjusted total assets. | Eli Lilly & Co. adjusted total asset turnover ratio deteriorated from 2021 to 2022 and from 2022 to 2023. |
Adjusted current ratio | A liquidity ratio calculated as adjusted current assets divided by adjusted current liabilities. | Eli Lilly & Co. adjusted current ratio deteriorated from 2021 to 2022 and from 2022 to 2023. |
Adjusted debt-to-equity ratio | A solvency ratio calculated as adjusted total debt divided by adjusted total equity. | Eli Lilly & Co. adjusted debt-to-equity ratio deteriorated from 2021 to 2022 and from 2022 to 2023. |
Adjusted debt-to-capital ratio | A solvency ratio calculated as adjusted total debt divided by adjusted total debt plus adjusted total equity. | Eli Lilly & Co. adjusted debt-to-capital ratio deteriorated from 2021 to 2022 and from 2022 to 2023. |
Adjusted financial leverage | A measure of financial leverage calculated as adjusted total assets divided by adjusted total equity. Financial leverage is the extent to which a company can effect, through the use of debt, a proportional change in the return on common equity that is greater than a given proportional change in operating income. |
Eli Lilly & Co. adjusted financial leverage ratio increased from 2021 to 2022 and from 2022 to 2023. |
Adjusted net profit margin | An indicator of profitability, calculated as adjusted net income divided by total revenue. | Eli Lilly & Co. adjusted net profit margin ratio deteriorated from 2021 to 2022 and from 2022 to 2023. |
Adjusted ROE | A profitability ratio calculated as adjusted net income divided by adjusted total equity. | Eli Lilly & Co. adjusted ROE deteriorated from 2021 to 2022 and from 2022 to 2023. |
Adjusted ROA | A profitability ratio calculated as adjusted net income divided by adjusted total assets. | Eli Lilly & Co. adjusted ROA deteriorated from 2021 to 2022 and from 2022 to 2023. |
Eli Lilly & Co., Financial Ratios: Reported vs. Adjusted
Adjusted Total Asset Turnover
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).
1 2023 Calculation
Total asset turnover = Revenue ÷ Total assets
= 34,124,100 ÷ 64,006,300 = 0.53
2 Adjusted total assets. See details »
3 2023 Calculation
Adjusted total asset turnover = Revenue ÷ Adjusted total assets
= 34,124,100 ÷ 58,441,400 = 0.58
Activity ratio | Description | The company |
---|---|---|
Adjusted total asset turnover | An activity ratio calculated as total revenue divided by adjusted total assets. | Eli Lilly & Co. adjusted total asset turnover ratio deteriorated from 2021 to 2022 and from 2022 to 2023. |
Adjusted Current Ratio
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).
1 2023 Calculation
Current ratio = Current assets ÷ Current liabilities
= 25,727,000 ÷ 27,293,200 = 0.94
2 Adjusted current assets. See details »
3 2023 Calculation
Adjusted current ratio = Adjusted current assets ÷ Current liabilities
= 25,639,400 ÷ 27,293,200 = 0.94
Liquidity ratio | Description | The company |
---|---|---|
Adjusted current ratio | A liquidity ratio calculated as adjusted current assets divided by adjusted current liabilities. | Eli Lilly & Co. adjusted current ratio deteriorated from 2021 to 2022 and from 2022 to 2023. |
Adjusted Debt to Equity
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).
1 2023 Calculation
Debt to equity = Total debt ÷ Total Eli Lilly and Company shareholders’ equity
= 25,225,300 ÷ 10,771,900 = 2.34
2 Adjusted total debt. See details »
3 Adjusted total equity. See details »
4 2023 Calculation
Adjusted debt to equity = Adjusted total debt ÷ Adjusted total equity
= 26,332,700 ÷ 5,402,700 = 4.87
Solvency ratio | Description | The company |
---|---|---|
Adjusted debt-to-equity ratio | A solvency ratio calculated as adjusted total debt divided by adjusted total equity. | Eli Lilly & Co. adjusted debt-to-equity ratio deteriorated from 2021 to 2022 and from 2022 to 2023. |
Adjusted Debt to Capital
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).
1 2023 Calculation
Debt to capital = Total debt ÷ Total capital
= 25,225,300 ÷ 35,997,200 = 0.70
2 Adjusted total debt. See details »
3 Adjusted total capital. See details »
4 2023 Calculation
Adjusted debt to capital = Adjusted total debt ÷ Adjusted total capital
= 26,332,700 ÷ 31,735,400 = 0.83
Solvency ratio | Description | The company |
---|---|---|
Adjusted debt-to-capital ratio | A solvency ratio calculated as adjusted total debt divided by adjusted total debt plus adjusted total equity. | Eli Lilly & Co. adjusted debt-to-capital ratio deteriorated from 2021 to 2022 and from 2022 to 2023. |
Adjusted Financial Leverage
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).
1 2023 Calculation
Financial leverage = Total assets ÷ Total Eli Lilly and Company shareholders’ equity
= 64,006,300 ÷ 10,771,900 = 5.94
2 Adjusted total assets. See details »
3 Adjusted total equity. See details »
4 2023 Calculation
Adjusted financial leverage = Adjusted total assets ÷ Adjusted total equity
= 58,441,400 ÷ 5,402,700 = 10.82
Solvency ratio | Description | The company |
---|---|---|
Adjusted financial leverage | A measure of financial leverage calculated as adjusted total assets divided by adjusted total equity. Financial leverage is the extent to which a company can effect, through the use of debt, a proportional change in the return on common equity that is greater than a given proportional change in operating income. |
Eli Lilly & Co. adjusted financial leverage ratio increased from 2021 to 2022 and from 2022 to 2023. |
Adjusted Net Profit Margin
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).
1 2023 Calculation
Net profit margin = 100 × Net income ÷ Revenue
= 100 × 5,240,400 ÷ 34,124,100 = 15.36%
2 Adjusted net income. See details »
3 2023 Calculation
Adjusted net profit margin = 100 × Adjusted net income ÷ Revenue
= 100 × 2,322,300 ÷ 34,124,100 = 6.81%
Profitability ratio | Description | The company |
---|---|---|
Adjusted net profit margin | An indicator of profitability, calculated as adjusted net income divided by total revenue. | Eli Lilly & Co. adjusted net profit margin ratio deteriorated from 2021 to 2022 and from 2022 to 2023. |
Adjusted Return on Equity (ROE)
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).
1 2023 Calculation
ROE = 100 × Net income ÷ Total Eli Lilly and Company shareholders’ equity
= 100 × 5,240,400 ÷ 10,771,900 = 48.65%
2 Adjusted net income. See details »
3 Adjusted total equity. See details »
4 2023 Calculation
Adjusted ROE = 100 × Adjusted net income ÷ Adjusted total equity
= 100 × 2,322,300 ÷ 5,402,700 = 42.98%
Profitability ratio | Description | The company |
---|---|---|
Adjusted ROE | A profitability ratio calculated as adjusted net income divided by adjusted total equity. | Eli Lilly & Co. adjusted ROE deteriorated from 2021 to 2022 and from 2022 to 2023. |
Adjusted Return on Assets (ROA)
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).
1 2023 Calculation
ROA = 100 × Net income ÷ Total assets
= 100 × 5,240,400 ÷ 64,006,300 = 8.19%
2 Adjusted net income. See details »
3 Adjusted total assets. See details »
4 2023 Calculation
Adjusted ROA = 100 × Adjusted net income ÷ Adjusted total assets
= 100 × 2,322,300 ÷ 58,441,400 = 3.97%
Profitability ratio | Description | The company |
---|---|---|
Adjusted ROA | A profitability ratio calculated as adjusted net income divided by adjusted total assets. | Eli Lilly & Co. adjusted ROA deteriorated from 2021 to 2022 and from 2022 to 2023. |